Glucagon-like peptide 1 agonists for treatment of patients with type 2 diabetes who fail metformin monotherapy: systematic review and meta-analysis of economic evaluation studies

OBJECTIVES: To conduct a systematic review and meta-analysis and to pool the incremental net benefits (INBs) of glucagon-like peptide 1 (GLP1) compared with other therapies in type 2 diabetes mellitus (T2DM) after metformin monotherapy failure. RESEARCH DESIGN AND METHODS: The study design is a syst...

Descripción completa

Detalles Bibliográficos
Autores principales: Bagepally, Bhavani Shankara, Chaikledkaew, Usa, Gurav, Yogesh Krishnarao, Anothaisintawee, Thunyarat, Youngkong, Sitaporn, Chaiyakunapruk, Nathorn, McEvoy, Mark, Attia, John, Thakkinstian, Ammarin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Epidemiology/Health Services Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371226/
https://www.ncbi.nlm.nih.gov/pubmed/32690574
http://dx.doi.org/10.1136/bmjdrc-2019-001020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371226/
https://www.ncbi.nlm.nih.gov/pubmed/32690574
http://dx.doi.org/10.1136/bmjdrc-2019-001020

Ejemplares similares